Pilar de la Rocha Mur/LinkedIn
Jul 11, 2026, 18:53
Pilar de la Rocha Mur: Why Trust Is the Most Valuable Currency in Clinical Research
Pilar de la Rocha Mur, Vice-President, Head of EMEA at BeOne Medicines, shared on LinkedIn:
”Trust is still the real currency in clinical research.
That was the theme that ran through the BeOne Medicines investigator meeting at EHA 2026 in Stockholm, and it’s one I keep coming back to.
Last night in Stockholm, I had the privilege of being in a room with some of Europe‘s leading hematology investigators.
Around 100 experts with one shared purpose: making clinical research better for patients.
What stayed with me the most was the quality of the conversation.
Here are my two takeaways from an evening that reminded me why this work matters.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE
-
Oct 12, 2026, 20:43Jazlyn A Selvasingh: Excited to Share Our Research at AAO-HNSF 2026 in Los Angeles
-
Oct 12, 2026, 20:31Natalia Kovtun: Higher Ferritin Cutoffs Now Define Iron Deficiency
-
Oct 12, 2026, 19:39Edward Loftus: Using Low-Dose Aspirin in Pregnant Women With IBD
-
Oct 12, 2026, 19:32Shruti Sachdeva: Strengthening the Fight against Anemia